WASHINGTON (Reuters) – Advisers to the U.S. Centers for Disease Control and Prevention will meet on Thursday to consider possible limits on the use of the Johnson & Johnson COVID-19 vaccine because of blood clot issues, the Washington Post reported on Wednesday.
Source: Read Full Article